Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03016689 · ClinicalTrials.gov registry record
The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 7
- Enrollment target
NCT03016689 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 7 participants.
The verdict
NCT03016689 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
While the maternal-newborn exchange of airway microbiota is well-documented, no studies have examined within-subject relationships among the mouth, sinuses, nasopharynx and lungs and the relative abundance of bacterial taxa at those sites. Recent evidence suggests the oral cavity may serve as a reservoir for pathogens that translocate to non-oral locations; oral-associated microbes infect most other body sites as evidence by 16S sequencing. By using a combination of oral and throat swabs, together with nasal suction of mucus samples, the investigators will use metagenomic sequencing to characterize the composition of bacterial communities at each anatomical site. Beginning at birth, a time-series of swabs will be collected from each subject, and monitor changes in the development of microbiota over time. By doing so, our studies will illuminate airway trafficking of both beneficial and pathogenic microbes and may represent an essential pathophysiological step towards shifting the balance between airway health and disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-05-31 |
| Est. Completion | 2019-09-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03016689
The ClinicalTrials.gov registry entry for NCT03016689 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03016689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03016689 about?
NCT03016689 is a clinical study titled "The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development". While the maternal-newborn exchange of airway microbiota is well-documented, no studies have examined within-subject relationships among the mouth, sinuses, nasopharynx and lungs and the relative abundance of bacterial taxa at those sites. Recent evidence suggests the oral cavity may serve as a rese...
What is the current status of trial NCT03016689?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2017-05-31. Estimated completion is 2019-09-12.
Who is sponsoring clinical trial NCT03016689?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.